Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.170

-2.5%

Nov 28 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LJM who wrote (2880)	2/23/2006 12:28:10 PM
From: JMarcus	Read Replies (1) of 3576

It looks like GERN's target date for the spinal cord therapeutic's IND has slipped by at least a quarter. <<The company will apply to the U.S. Food and Drug Administration in the fourth quarter of 2006 to begin the trials on spinal cord victims, he added. >> Last May, at the stockholders meeting, Okarma was targeting mid-2006 for the IND. That's a modest amount of slippage (for Okarma). Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next